<DOC>
	<DOCNO>NCT01076491</DOCNO>
	<brief_summary>This study investigate safety tolerability high dos inhale mannitol subject bronchiectasis direct development improve drug delivery system .</brief_summary>
	<brief_title>High Dose Inhaled Mannitol Study</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>adult subject nonCF bronchiectasis FEV1 &gt; 50 % predict &gt; 1.0L bronchiectasis due CF endobronchial lesion respiratory infection require IV antibiotic last 4 week pregnancy significant haemoptysis last 6 month active TB end stage ILD contraindication determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>